Lafeber M, Grobbee D E, Schrover I M, Thom S, Webster R, Rodgers A, Visseren F L J, Bots M L, Spiering W
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Int J Cardiol. 2015 Feb 15;181:193-9. doi: 10.1016/j.ijcard.2014.11.176. Epub 2014 Dec 3.
Cardiovascular polypills are a novel strategy in the prevention of cardiovascular disease. Based on considerations about the effectiveness, the individual pills of a polypill are taken at different times of the day. This study aimed therefore to compare the use of a polypill in the morning, in the evening or the individual components taken at their usual times on cardiovascular risk factors and patient acceptability.
The study was a randomized three-period crossover trial. Seventy-eight patients with established cardiovascular disease were randomly allocated to the use of polypill (aspirin 75 mg, simvastatin 40 mg, lisinopril 10mg and hydrochlorothiazide 12.5mg) in the morning, in the evening or use of the individual agents taken at different time points (Trial: NCT01506505).
Using the polypill in the evening resulted in a 0.2 mmol/L (95%-confidence interval (CI): 0.1 to 0.3) lower fasting LDL-cholesterol compared to the use in the morning, and not statistically significantly different mean 24-hour systolic BP (mean difference: 0.7 mmHg; 95%-CI; -2.1 to 3.4). Compared to the use of the individual agents, the mean LDL-cholesterol was 0.2 mmol/L (95%-CI: 0.1 to 0.3) higher when using the polypill in the morning, but not statistically significantly different when used in the evening (mean difference: -0.1 mmol/L; 95%-CI: -0.1 to 0.0). Furthermore, there were no differences in mean 24-hour systolic BP with morning use (mean difference: 0.4 mmHg; 95%-CI; -1.5 to 2.3) or evening use (mean difference: 1.0mmHg; 95%-CI; -0.8 to 2.8) of the polypill compared to the individual agents. The adherence was 5.2% (95%-CI: 1.4 to 9.1) higher with morning use of the polypill and 5.0% (95%-CI: 1.5 to 8.5) higher with evening use compared to the individual agents. Treatment with the polypill was preferred by 92% of the participants.
The use of a polypill in the evening was more effective in lowering LDL-cholesterol, and resulted in not statistically significantly different ambulatory BP levels compared to the use of a polypill in the morning. Therapy with a polypill was associated with an increased adherence. The polypill is highly preferred by patients, demonstrating a potential role for the polypill in the prevention of cardiovascular disease.
心血管复方制剂是预防心血管疾病的一种新策略。基于有效性的考虑,复方制剂中的各个药丸在一天中的不同时间服用。因此,本研究旨在比较早晨、晚上服用复方制剂或按常规时间服用各单一成分对心血管危险因素及患者可接受性的影响。
本研究为随机三阶段交叉试验。78例确诊心血管疾病的患者被随机分配为早晨服用复方制剂(阿司匹林75毫克、辛伐他汀40毫克、赖诺普利10毫克和氢氯噻嗪12.5毫克)、晚上服用复方制剂或在不同时间点服用各单一药物(试验注册号:NCT01506505)。
与早晨服用复方制剂相比,晚上服用复方制剂可使空腹低密度脂蛋白胆固醇降低0.2毫摩尔/升(95%置信区间(CI):0.1至0.3),24小时平均收缩压无统计学显著差异(平均差值:0.7毫米汞柱;95%CI:-2.1至3.4)。与服用各单一药物相比,早晨服用复方制剂时平均低密度脂蛋白胆固醇高0.2毫摩尔/升(95%CI:0.1至0.3),晚上服用时无统计学显著差异(平均差值:-0.1毫摩尔/升;95%CI:-0.1至0.0)。此外,与服用各单一药物相比,早晨服用复方制剂时24小时平均收缩压无差异(平均差值:0.4毫米汞柱;95%CI:-1.5至2.3),晚上服用时也无差异(平均差值:1.0毫米汞柱;95%CI:-0.8至2.8)。与服用各单一药物相比,早晨服用复方制剂的依从性高5.2%(95%CI:1.4至9.1),晚上服用高5.0%(95%CI:1.5至8.5)。92%的参与者更喜欢使用复方制剂进行治疗。
与早晨服用复方制剂相比,晚上服用复方制剂在降低低密度脂蛋白胆固醇方面更有效,且动态血压水平无统计学显著差异。使用复方制剂治疗可提高依从性。患者非常喜欢复方制剂,表明其在预防心血管疾病方面具有潜在作用。